Renzapride: a new drug for the treatment of constipation in the irritable bowel syndrome.
D000818:Animals; D001549:Benzamides / Q000494:pharmacology / Q000627:therapeutic use*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology / Q000627:therapeutic use*; D003248:Constipation / Q000150:complications* / Q000188:drug therapy* / Q000378:metabolism; D005755:Gastrins / Q000378:metabolism; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000150:complications* / Q000188:drug therapy* / Q000378:metabolism; D009037:Motilin / Q000378:metabolism
D001549:Benzamides; D019086:Bridged Bicyclo Compounds, Heterocyclic; D005755:Gastrins; D009037:Motilin; C053006:renzapride